J R Whittington

415 total citations
20 papers, 279 citations indexed

About

J R Whittington is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, J R Whittington has authored 20 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 5 papers in Pharmacology. Recurrent topics in J R Whittington's work include Blood Pressure and Hypertension Studies (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). J R Whittington is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). J R Whittington collaborates with scholars based in United Kingdom, Germany and United States. J R Whittington's co-authors include M. W. Millar-Craig, Debra Hawes, Edward B. Raftery, Avijit Lahiri, Ravinder S. Kohli, Erwin A. Rodrigues, E. B. Raftery, Liam O. Hughes, Travis B. Dick and Amos Pines and has published in prestigious journals such as The American Journal of Cardiology, Cardiovascular Research and Heart.

In The Last Decade

J R Whittington

19 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J R Whittington United Kingdom 9 176 67 43 34 25 20 279
Edmund Sonnenblick United States 8 181 1.0× 79 1.2× 28 0.7× 30 0.9× 24 1.0× 10 353
L Atkinson United Kingdom 10 201 1.1× 60 0.9× 74 1.7× 65 1.9× 29 1.2× 16 312
R Fariello Italy 9 201 1.1× 65 1.0× 21 0.5× 25 0.7× 43 1.7× 39 423
Joanne Stock United Kingdom 11 217 1.2× 73 1.1× 39 0.9× 14 0.4× 28 1.1× 16 394
K. Venkataraman United States 13 419 2.4× 66 1.0× 59 1.4× 30 0.9× 23 0.9× 23 539
E Lorentsen Norway 11 239 1.4× 138 2.1× 40 0.9× 22 0.6× 27 1.1× 23 395
Soad Bekheit United States 14 536 3.0× 94 1.4× 36 0.8× 35 1.0× 14 0.6× 37 657
B. Pitt United States 10 220 1.3× 59 0.9× 71 1.7× 10 0.3× 34 1.4× 16 298
Jean–Paul Bounhoure France 10 252 1.4× 36 0.5× 22 0.5× 13 0.4× 39 1.6× 47 325
M. Tauchert Germany 13 249 1.4× 56 0.8× 116 2.7× 40 1.2× 31 1.2× 71 443

Countries citing papers authored by J R Whittington

Since Specialization
Citations

This map shows the geographic impact of J R Whittington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J R Whittington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J R Whittington more than expected).

Fields of papers citing papers by J R Whittington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J R Whittington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J R Whittington. The network helps show where J R Whittington may publish in the future.

Co-authorship network of co-authors of J R Whittington

This figure shows the co-authorship network connecting the top 25 collaborators of J R Whittington. A scholar is included among the top collaborators of J R Whittington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J R Whittington. J R Whittington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkins, Robert A., et al.. (1989). Safety and Pharmacokinetics of Ioversol in Healthy Volunteers. Investigative Radiology. 24(Supplement 1). S28–S28. 1 indexed citations
2.
Wilkins, Robert A., et al.. (1989). Safety and Pharmacokinetics of Ioversol in Healthy Volunteers. Investigative Radiology. 24(10). 781–788. 14 indexed citations
3.
Lahiri, Avijit, et al.. (1989). Buccal Nitroglycerin and Intravenous Isosorbide Dinitrate inUnstable Angina. American Journal of Noninvasive Cardiology. 3(5). 281–289. 5 indexed citations
4.
Kohli, Ravinder S., et al.. (1986). Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris. The American Journal of Cardiology. 58(9). 727–731. 33 indexed citations
5.
Khurmi, Nardev S., et al.. (1986). Transmucosal and transdermal nitroglycerin delivery systems for prevention of chronic stable angina pectoris. International Journal of Clinical Practice. 40(5). 187–191. 3 indexed citations
6.
Caruana, M., et al.. (1986). Once-and twice-daily bevantolol for systemic hypertension using 24-hour ambulatory intraarterial blood pressure recording. The American Journal of Cardiology. 58(12). E17–E20. 6 indexed citations
7.
Caruana, M., et al.. (1986). Nicardipine and verapamil in essential hypertension. British Journal of Clinical Pharmacology. 22(s3). 6 indexed citations
8.
Rodrigues, Erwin A., Avijit Lahiri, Liam O. Hughes, et al.. (1986). Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity. The American Journal of Cardiology. 58(10). 916–921. 31 indexed citations
9.
Lahiri, Avijit, et al.. (1985). Detection of high risk coronary artery disease by thallium imaging.. Heart. 53(6). 616–623. 14 indexed citations
10.
Pines, Amos, H. Raafat, Anthony Lynn, & J R Whittington. (1984). Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy. Current Medical Research and Opinion. 8(10). 734–742. 13 indexed citations
11.
Whittington, J R. (1983). Microcomputers in epidemiological study. BMJ. 287(6397). 985.1–985.
12.
Whittington, J R, et al.. (1983). Placebo-controlled trial of a combination of bemetizide and triamterene (‘Hypertane’) in mild or moderate hypertension. Current Medical Research and Opinion. 8(6). 425–433. 1 indexed citations
13.
Wray, Richard, et al.. (1983). Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension. Current Medical Research and Opinion. 8(9). 665–674. 1 indexed citations
14.
Fernandes, L., et al.. (1982). Comparative trial of standard and sustained-release formulations of ibuprof en in patients with osteoarthritis. Current Medical Research and Opinion. 7(9). 610–623. 5 indexed citations
15.
Dick, Travis B., et al.. (1981). Comparative study of once and 3-times daily regimens of bezafibrate in patients with primary hyperlipoproteinaemia. Current Medical Research and Opinion. 7(8). 489–502. 13 indexed citations
16.
Spear, F. G., et al.. (1980). A double-blind controlled trial of mianserin and amitriptyline in depression. Current Medical Research and Opinion. 7(1). 14–22. 6 indexed citations
17.
Whittington, J R & E. B. Raftery. (1980). A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris.. British Journal of Clinical Pharmacology. 10(3). 211–215. 8 indexed citations
18.
Whittington, J R & E. B. Raftery. (1980). Oxyfederine and propranolol—a controlled trial in angina pectoris.. British Journal of Clinical Pharmacology. 10(5). 439–442. 2 indexed citations
19.
Whittington, J R, et al.. (1979). An effective conscious animal model of atrial fibrillation. Cardiovascular Research. 13(2). 105–112. 8 indexed citations
20.
Millar-Craig, M. W., Debra Hawes, & J R Whittington. (1978). New system for recording ambulatory blood pressure in man. Medical & Biological Engineering & Computing. 16(6). 727–731. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edmund Sonnenblick Breakdown of academic impact, for papers by L Atkinson Breakdown of academic impact, for papers by R Fariello Breakdown of academic impact, for papers by Joanne Stock Breakdown of academic impact, for papers by K. Venkataraman Breakdown of academic impact, for papers by E Lorentsen Breakdown of academic impact, for papers by Soad Bekheit Breakdown of academic impact, for papers by B. Pitt Breakdown of academic impact, for papers by Jean–Paul Bounhoure Breakdown of academic impact, for papers by M. Tauchert
Rankless by CCL
2026